Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2009
10/01/2009WO2009120080A1 Chewing gum compositions comprising cannabinoids
10/01/2009WO2009119992A2 Percutaneous preparation comprising fentanyl
10/01/2009WO2009119836A1 Composition for external application comprising transcription factor decoy as active ingredient
10/01/2009WO2009119673A1 Transdermally absorbable preparation
10/01/2009WO2009119672A1 COMPOSITION FOR STABILIZING β-BLOCKER, AND TRANSDERMALLY ABSORBABLE PREPARATION COMPRISING THE COMPOSITION
10/01/2009WO2009119601A1 Water-based adhesive skin patch comprising ketoprofen lysine salt
10/01/2009WO2009119290A1 Oral preparation
10/01/2009WO2009118764A1 Pharmaceutical composition comprising diclofenac and paracetamol
10/01/2009WO2009118763A1 Multilayered pharmaceutical compositions and processes thereof
10/01/2009WO2009118756A2 Delayed release compositions of duloxetine
10/01/2009WO2009118589A2 Orally disintegrating compositions of rhein or diacerein
10/01/2009WO2009118562A1 Pharmaceutical composition 271
10/01/2009WO2009118465A1 Oral pharmaceutical formulation comprising a soluble or dispersible single-unit dose tablet, such as an effervescent tablet
10/01/2009WO2009118359A2 Capsule for the prevention of cardiovascular diseases
10/01/2009WO2009118356A2 Preparation method for solid disupersions
10/01/2009WO2009118322A1 Process for preparing orally administered dabigatran formulations
10/01/2009WO2009118321A1 Method for manufacturing acid pellets
10/01/2009WO2009118259A1 Ptph1 inhibitors for the treatment of alzheimer's disease
10/01/2009WO2009118191A2 Therapy for vitiligo
10/01/2009WO2009118167A1 Pharmaceutical formulation comprising a solid dispersion and method for the production thereof
10/01/2009WO2009117952A1 A pharmaceutical composition with effects of antitussive, antiasthma, moisturizing throat and dissipating phlegm and its preparation method
10/01/2009WO2009117938A1 A pharmaceutical composition with effect of anti-fatigue, its preparation method and its use
10/01/2009WO2009117936A1 A pharmaceutical composition with effects of antipyretic, anti-inflammatory and analgesia and its preparation method
10/01/2009WO2009117819A1 Methylphenidate extended release therapeutic drug delivery system
10/01/2009WO2009100137A3 Magnetic cells for localizing delivery and tissue repair
10/01/2009WO2009097508A3 Methods and compositions for wound healing
10/01/2009WO2009094191A3 Methods of treating viral infections
10/01/2009WO2009094190A3 Methods of treating viral infections
10/01/2009WO2009092094A3 Method and device for repair of degenerative cartilage
10/01/2009WO2009091531A3 Uniform-sized, multi-drug carrying and photosensitive liposomes for advance drug delivery
10/01/2009WO2009091346A3 Stable pharmaceutical formulation and preparation methods
10/01/2009WO2009085273A3 Use of anti-connexin polynucleotides for the treatment of surgical adhesions
10/01/2009WO2009085268A3 Use of anti-connexin peptides, alone or in combination with anti-connexin polynucleotides, for the treatment of surgical adhesions
10/01/2009WO2009082449A3 Resuscitation fluid
10/01/2009WO2009071326A3 Transdermal therapeutic system having a content of a modulator for nicotinic acetylcholine receptors (nachr)
10/01/2009WO2009049648A3 Improved pharmaceutical composition containing antiviral agent and method for the preparation thereof
10/01/2009WO2008154339A9 Extended release formulation and method of treating adrenergic dysregulation
10/01/2009US20090247778 Star polymer such as of a polylactone based on a central phosphorus atom derived from phosphorus oxychloride (POCl3) or ethyl dichlorophosphate; biodegradable and/or biocompatible; sustained release drug delivery; reverse thermal gelation
10/01/2009US20090247738 Biocompatible poly-beta-1-4-n-acetylglucosamine
10/01/2009US20090247632 Dermatological compositions and methods
10/01/2009US20090247580 Nitroxide radioprotector formulations and methods of use
10/01/2009US20090247491 Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition and use thereof
10/01/2009US20090247463 Polymer-based sustained release device
10/01/2009US20090247460 Inhibitor of vascular endothelial cell growth factor
10/01/2009US20090246288 Taste-masking oral dosage form and method of preparing the same
10/01/2009US20090246287 Anti-allergy compositions
10/01/2009US20090246286 Particle for Medical Use and Process for Producing the Same
10/01/2009US20090246285 Monodispersed organic monolayer coated calcium-containing nanoparticles
10/01/2009US20090246284 O-desmethylvenlafaxine Cocrystals
10/01/2009US20090246283 Repeat Sequence Protein Polymer Nanoparticles Optionally Containing Active Agents and Their Preparation
10/01/2009US20090246282 Recombinant gelatin particles for cell adhesion
10/01/2009US20090246281 Soft steroid compositions for use in dry powder inhalers
10/01/2009US20090246280 Resin Powder Containing Aluminum Salt, Process for Production of the Same, and Resin Composition, Phosphorus Adsorbent, Antibacterial Agent or Antifungal Agent Comprising the Same
10/01/2009US20090246279 Particles having hydrophobic material therein
10/01/2009US20090246278 Use of essential oils to reduce benzodiazepine requirements during medical procedures
10/01/2009US20090246277 Controlled release system
10/01/2009US20090246276 Pharmaceutical Compositions
10/01/2009US20090246275 Compositions and methods for delivery of embolics
10/01/2009US20090246274 Pharmaceutical composition 271
10/01/2009US20090246273 Ketorolac Sublingual Spray for the Treatment of Pain
10/01/2009US20090246272 Mda-7 proteins and methods of use thereof
10/01/2009US20090246271 Combination of ceramide and gemcitabine for inducing cell death and uses thereof in treating cancer
10/01/2009US20090246270 Use of Iontophoresis or Electrotherapy and Ultrasound to Deliver Agents for Skin Rejuvenation.
10/01/2009US20090246269 Identification and use of gprc variants in the treatment and diagnosis of parkinson's disease
10/01/2009US20090246268 Liposomal, ring-opened camptothecins with prolonged, site-specific delivery of active drug to solid tumors
10/01/2009US20090246267 Carnitine Conjugates of Adamantanamines and Neramexane Derivatives as Dual Prodrugs for Various Uses
10/01/2009US20090246266 Preparation and composition of meloxicam transdermal drug delivery system
10/01/2009US20090246265 Abuse deterrent transdermal formulations of opiate agonists and agonist-antagonists
10/01/2009US20090246264 Transdermal Tobacco Alkaloid Patch
10/01/2009US20090246262 Easily applied field dressing for wounds
10/01/2009US20090246261 Fibrin foam and process for making
10/01/2009US20090246259 Biocompatible material having biocompatible non-woven nano- or micro-fiber fabric produced by electrospinning method, and method for production of the material
10/01/2009US20090246258 Antimicrobial and odor adsorbing textile
10/01/2009US20090246257 Wafer formulation
10/01/2009US20090246256 Compositions and Methods for Transmucosal Delivery of Lofexidine
10/01/2009US20090246254 Non-hormonal vaginal contraceptive
10/01/2009US20090246253 Methods Of Providing Antioxidants To Implantable Medical Devices
10/01/2009US20090246245 Subcutaneous implants releasing an active principle over an extended period of time
10/01/2009US20090246244 Malleable multi-component implants and materials therefor
10/01/2009US20090246238 Reinforced absorbable multilayered hemostatic wound dressing
10/01/2009US20090246234 Therapeutic Treatment Using Niacin for Skin Disorders
10/01/2009US20090246233 Treatment of Gastroparesis and Nonulcer Dyspepsia With GABAB Agonists
10/01/2009US20090246232 Pharmaceutical composition
10/01/2009US20090246231 Formulations containing borojo
10/01/2009US20090246209 Gnrh analogues for treatment of urinary incontinence
10/01/2009US20090246167 Stimuli-responsive systems for controlled drug delivery
10/01/2009US20090246149 Medicinal aerosol formulations
10/01/2009US20090246148 Medicinal aerosols and methods of delivery thereof
10/01/2009US20090246147 Delivery Of Antipsychotics Through An Inhalation Route
10/01/2009US20090246146 Halides in the treatment of pathogenic infection
10/01/2009US20090246142 Triggered Self-Assembly of Nanoparticles In Vivo
10/01/2009US20090246127 Targeting agents for molecular imaging
10/01/2009US20090241950 Method of treating diabetes mellitus in a patient
10/01/2009CA2756690A1 Administration of benzodiazepine compositions
10/01/2009CA2720800A1 Capsule for the prevention of cardiovascular diseases
10/01/2009CA2719921A1 Orally-administered agent
10/01/2009CA2719830A1 Chewing gum compositions comprising cannabinoids
10/01/2009CA2719811A1 Fenofibrate dosage forms
10/01/2009CA2719803A1 Compositions and methods for the preparation of nanoemulsions
10/01/2009CA2719751A1 Oral and injectable formulations of tetracycline compounds
1 ... 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 ... 2991